SCHEMBL30795168

SCHEMBL30795168

O=C1N[C@H](c2cc(C#Cc3ccnc(F)c3)cnc2F)[C@@H](c2cccc(F)c2)O1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4537802 1.00 GRM5 (0.67) GRM5
SCHEMBL4539792 0.88 GRM5 (0.72) GRM5
SCHEMBL4539399 0.86 GRM5 (0.67) GRM5
SCHEMBL4536781 0.86 GRM5 (0.69) GRM5
SCHEMBL30795734 0.86 GRM5 (0.69) GRM5
SCHEMBL4539243 0.86 GRM5 (0.66) GRM5
SCHEMBL4539624 0.85 GRM5 (0.70) GRM5
SCHEMBL4540797 0.85 GRM5 (0.65) GRM5
SCHEMBL5021631 0.84 GRM5 (0.56) GRM5
SCHEMBL4537098 0.84 GRM5 (0.68) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584250-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS Biohaven Therapeutics Ltd. (VG) 2025-07-16 EP disclosed
WO-2024054811-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD. (VG) 2024-03-14 WO disclosed